Apr 18, 2012
112th Congress, 2011–2013
Died in a previous Congress
This bill was introduced on April 18, 2012, in a previous session of Congress, but was not enacted.
Senior Senator from Vermont
Read Text »
Last Updated: Apr 18, 2012
Length: 2 pages
About the bill
A bill to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand names to do so.
The bill’s titles are written by its sponsor.
This is the first step in the legislative process.
Links & tools
Click a format for a citation suggestion:
Civic Impulse. (2016). S. 2295 — 112th Congress: Patient Safety and Generic Labeling Improvement Act. Retrieved from https://www.govtrack.us/congress/bills/112/s2295
“S. 2295 — 112th Congress: Patient Safety and Generic Labeling Improvement Act.” www.GovTrack.us. 2012. September 25, 2016 <https://www.govtrack.us/congress/bills/112/s2295>
|title=S. 2295 (112th)
|accessdate=September 25, 2016
|author=112th Congress (2012)
|date=April 18, 2012
|quote=Patient Safety and Generic Labeling Improvement Act